Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

EUPROTEIN Launched the Supreme Humanly-Expressed Proteins to Help Research in SARS-CoV-2

Author: Greg Inman
by Greg Inman
Posted: Aug 28, 2020
recombinant proteins

NJ based bioreagent manufacturer, EUPROTEIN Inc., has recently developed a series of SARS-CoV-2 antigens and the associated cellular receptor protein. These high-quality proteins are all expressed in human cell, can be used for basic research study towards 2019-nCoVs, and would also help in potential diagnostic and therapeutic developments for the SARS-CoV-2 and related COVID-19 diseases. Find out details by visiting: https://www.euprotein.com/feature_protein/SARS_CoV_2

EUPROTEIN Inc., the expert in mammalian expressed protein, has launched the full set of their top-quality recombinant proteins, adding to their selection of over 1000 mammalian expressed recombinant proteins. These protein are expressed in human mammalian cells, which inherently is of superior quality compared to similar proteins expressed from E. Coli. Their product quality has been validated and verified by enthusiastic clients who puts up huge demands of delivery.

Across the world, biological reagents providers such as EUPROTEIN are at the very core of the coordinated effort to combat the global pandemic COVID-19. Thanks to their innovation and tireless 24x7 work, medical research teams are provided with proteins and antibodies of premier quality, that helps to increase the speed at which they are able to carry crucial research into the way disease develops, thus accelerating potential cure discovery. Currently, the company offers a wide array of recombinant proteins and antibodies that are manufactured in their North Brunswick, NJ based facility. Products are distributed via FedEx Priority Overnight which is guaranteed to get delivered within 24 hours to any customer located within continental US.

As research teams at top pharmaceutical companies are all striving to search for cues and clue to fight this pandemic COVID-19, it is protein development specialists like EUPROTEIN who is providing the tools for their high priority work. Through the new additions to the their catalogue, it is hoped that the EUPROTEIN can continue to contribute to biomedical discovery of cure to end this pandemic.

To learn more about their product offering, please visit https://www.euprotein.com/feature_protein/SARS_CoV_2

Coronaviruses (CoVs) are a large group of viruses that commonly originate in many different species of animals. Some coronaviruses can make a jump from animals to human, and cause the respiratory infections including mild and cold-like symptoms. A couple of coronaviruses including Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), are much more severe and have killed thousands of people.

2019-nCoV, officially named as SARS-CoV-2, is another contagious and novel coronavirus that can infect people and cause outbreak of respiratory illness (COVID-19). It was first detected in Wuhan, China in December, 2019, and is being reported in a growing number of international locations. The rapid person-to-person spread of SARS-CoV-2 presents a imminent threat to the global public health. It was declared as pandemic by WHO on March 11th 2020. As of August 21, 2020, over 22,789,700 COVID-19 cases caused by SARS-CoV-2 have been recorded worldwide, and more than 795,500 people have been reported dead.

Chinese health authorities were the first to isolate the SARS-CoV-2, the Wuhan seafood market pneumonia virus isolate Wuhan-Hu-1, and published the full genome sequence of the 2019-nCoV which is ~90% of nucleotide similarity to a group of SARS-like coronaviruses. Protein sequence analysis revealed that 2019-nCoV shares ~80% sequence identity to SARS-CoV, and 96% identity to a bat coronavirus at the whole-genome level. US CDC has also posted the full genome of the SARS-CoV-2 viruses detected in U.S. patients, and found the sequences from US patients similar to the one that China initially posted.

The full spectrum of SARS-CoV-2 related proteins include (but not limited to):

  • SARS-CoV-2 Spike S1 Protein - SARS-CoV-2 Spike S1 RBD Protein - SARS-CoV-2 Spike S Protein (S1+S2)
  • SARS-CoV-2 Nucleocapsid Protein (N Protein)
  • Recombinant Human ACE2 Protein
About the Author

The expert in mammalian expressed protein, 30 years of experience in the industry, excellent quality, excellent customer service

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
  • Guest  -  2 months ago

    Hmm it appears like your website ate my first comment (it was extremely long) so I guess I'll just sum it up what I had written and say, I'm thoroughly enjoyin your blog. I too am an aspiring blog writer bbut I'm stilll new to everything. Do you have any recommendations for novice blog writers? I'd genuinely appreciate it. Bet match web page bis on presidential elections 2019

Author: Greg Inman

Greg Inman

Member since: Aug 25, 2020
Published articles: 2

Related Articles